David Khan, M.D.
Dr. David Khan specializes in radiation oncology and he is currently affiliated with Cedars-Sinai Marina del Rey Hospital. He earned his medical degree from Oregon Health and Science University School of Medicine and was fellowship-trained in Anatomic Pathology by New York University School of Medicine. The physician is a member of the Radiation Therapy Oncology Group, the American Medical Association, and the American Society for Therapeutic Radiology and Oncology. Dr. David Khan's clinical interests are intensity-modulated radiotherapy, stereotactic body radiotherapy, stereotactic radiosurgery, and high dose rate brachytherapy for breast malignancies.
In addition to his busy clinical practice, he has extensive clinical research and has numerous publications on cancer care disparity, prostate cancer, and breast cancer. In recognition of his superior clinical acumen and compassionate bedside manner, Dr. David Khan has been selected as one of the Best Doctors in America since 2008. The physician has over 25 years of professional experience and in 1990, he also underwent a summer Research Fellowship in Otolaryngology. In 1989, Dr. David Khan earned a Bachelor of Arts in Psychooncology from Pomona College. He is certified by the American Board of Radiology.
Procedures Dr. David Khan Performs at Cedars-Sinai Marina del Rey Hospital
Insurance Accepted
- Aetna
- Blue Cross / Blue Shield
- Cigna
- Coventry Health Care
- HealthNet
Languages Spoken
- English
- Spanish
- Vietnamese
Education & Training
Medical Degree
Oregon Health and Science University School of Medicine
Internship(s)
New York University - Internal Medicine
Residency(ies)
New York University School of Medicine - Radiation Oncology, Chief Resident New York
Fellowship(s)
Oregon Health Sciences University - Anatomic Pathology
Memberships & Affiliations
Radiation Therapy Oncology Group
American College of Radiation Oncology
American Medical Association
American Society for Therapeutic Radiology & Oncology
Los Angeles Radiological Society
Publications & Media
-
Preliminary results and evaluation of MammoSite balloon brachtherapy for partial breast irradiation for pure ductal carcinoma in-situ: a phase II clinical study.
Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keish M, Dipetrillo T, Khan D, Hudes R
-
Abnormal Cochlear Connective Tissue Mineralization in the Palmerston North Autoimmune Mouse.
Khan DC, DeGagne JM, Trune DR
-
Lay patient navigator program implementation for equal access to cancer care and clinical trials: essential steps and initial challenges.
Michael L. Steinberg, Allen Fremont, David C. Khan, David T. Huang, Herschel Knapp, Deborah Karaman, Nell Griffith Forge, Keith Andre, Lisa M. Chaiken, Oscar E. Streeter
-
Radiotherapy for the treatment of giant cell tumor of the spine: a report of six cases and review of the literature.
Khan, D. C., Malhotra, S., Stevens, R. E., Steinfeld, A. D.; Cancer Invest. 1999 Jan 01.
-
Reduction in patient-reported acute morbidity in prostate cancer patients treated with 81-Gy Intensity-modulated radiotherapy using reduced planning target volume margins and electromagnetic tracking: assessing the impact of margin reduction study.
H. M. Sandler; P. Y. Liu; R. L. Dunn; D. C. Khan; S. E. Tropper; M. G. Sanda; C. A. Mantz